CRINETICS PHARMACEUTICALS IN
CRNX·22663K107·US·Common Stock·Healthcare - Biotechnology-13D/G
CRNX (CRINETICS PHARMACEUTICALS IN) is held by 135 institutional investors as of Q2 2026. Largest holders: FMR LLC ($592.7M), BlackRock, Inc. ($365.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($336.4M). Net institutional sentiment: Mixed.
135
Holders
(11 Elite)
$3.5B
Total Value
59% (138)
Consensus
82 buying - 56 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 24, 2026 · Activists Aug 13, 2026 · Congress none
InsiderSTSchilke TobinVest 471 shAug 20, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 148
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer